Having demonstrated the ability of CO to prevent IUGR and fetal death caused by insufficient HO-1 levels [12], we concentrated on analyzing the therapeutic potential of CO in a clinically relevant model of IUGR as in humans a relationship between IUGR and low HO-1 activity has been widely demonstrated [37]. The gene discussed is HMOX1; the disease is fetal growth restriction.